However, aberrant p120ctn expression has been reported as an independent prognostic marker in gastroesophageal adenocarcinoma, breast cancer, bladder cancer, lung cancer and colorectal cancer [27, 28, 31, 36]. This evidence concerns the gene CTNND1 and urinary bladder cancer.